April 14, 2025

FDA Clears Tablet for Cholestatic Pruritus

The FDA has approved a tablet formulation of maralixibat (LIVMARLI) for treating cholestatic pruritus in patients with Alagille syndrome and progressive familial intrahepatic cholestasis.

Conexiant

April 14, 2025

Pfizer Halts Danuglipron Obesity Pill Trials

Pfizer discontinues development of potential weight-loss drug due to liver injury in trial participant, impacting stock prices and future strategies.

Reuters

April 04, 2025

First IgG4-RD Treatment Approved

A humanized monoclonal antibody that targets CD19+ B cells is first FDA-approved treatment for immunoglobulin G4–related disease, reducing flare risk and glucocorticoid use in clinical trials.

Conexiant

April 01, 2025

Medical Oddities: Shrinking Brains, Failing Hearts?

Brains shrink, bots soothe, tea disappoints, and love gets the hormonal spotlight it deserves this week.

Conexiant

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 27, 2025

Hypoglycemia Cases Tied to Slush Drinks

A new study identifies glycerol intoxication syndrome in children after consuming slush ice drinks, leading to hypoglycemia, metabolic acidosis, and altered consciousness.

Conexiant

March 25, 2025

Not All Plant-Based Diets Are Equal

Higher adherence to a healthy plant-based diet linked to lower IBD risk.

Conexiant

March 25, 2025

Not All Plant-Based Diets Are Equal

Higher adherence to a healthy plant-based diet linked to lower IBD risk.

Conexiant

March 19, 2025

Study: Sex Differences in Physician Suicide

Researchers found that female physicians had a significantly higher suicide risk than female nonphysicians.

Conexiant